Table 1.
Laboratory findings of the present case
| Complete blood count | Blood urea nitrogen | 60.7 mg/dL | Serum M protein | Negative | |
| White blood cell | 14,600 /μL | Creatinine | 2.94 mg/dL | Platelet-associated IgG | 238.0 ng/107 cells |
| Neutrophil | 84.6% | C-reactive protein | 14.25 mg/dL | Anti-platelet Ab | Negative |
| Lymphocyte | 9.4% | β-D-glucan | < 6.0 pg/mL | Soluble IL-2 receptor | 1120 U/mL |
| Monocyte | 5.6% | Ferritin | 419 ng/mL | Direct Coombs test | Negative |
| Basophil | 0.1% | Serum iron | 9 μg/dL | Indirect Coombs test | Negative |
| Eosinophil | 0.0% | Total iron binding capacity | 155 μg/dL | IL-6 (serum, on day 9) | 25.2 pg/mL |
| Red blood cell | 426 × 104 /μL | Haptoglobin | 268 mg/dL | VEGF (plasma, on day 9) | 224 pg/mL |
| Hemoglobin | 11.7 g/dL | Thyroid stimulating hormone | 6.4 μIU/ml | IL-6 (ascites, on day 9) | 3310 pg/mL |
| Hematocrit | 34.8% | Free T3 | 1.4 pg/ml | VEGF (ascites, on day 9) | 335 pg/mL |
| Reticulocyte | 15‰ | Free T4 | 1.1 ng/dl | STS | Negative |
| Platelet | 11.1 × 104 /μL | BNP | 61 pg/mL | HBs Ag | Negative |
| IPF | 10.9% | CEA | 0.5 U/mL | HBs Ab | Negatve |
| Coagulation test | CA19–9 | 5 ng/mL | HBc Ab | Negative | |
| APTT | 45.3 s | IgA | 264 mg/dL | HCV Ab | Negative |
| PT-INR | 1.30 | IgG | 2461 mg/dL | HIV Ab | Negative |
| Fibrinogen | 479 mg/dL | IgG4 | 235 mg/dL | IFN-γ release assay | Negative |
| Blood chemistry and immunological tests | IgM | 88 mg/dL | Helicobacter pylori IgG | Negative | |
| Sodium | 138 mEq/L | ANA | Positive (×40) | CMV-IgG | Positive |
| Potassium | 4.1 mEq/L | RF | 2 U/mL | CMV-IgM | Negative |
| Chloride | 101 mEq/L | CH50 | 44.9 U/mL | EBV VCA-IgG Ab | Positive |
| Calcium | 8.1 mg/dL | C3 | 50 mg/dL | EBV VCA-IgM Ab | Negative |
| Total protein | 6.4 g/dL | C4 | 14 mg/dL | EBNA Ab | Positive |
| Albumin | 2.1 g/dL | Anti-ds-DNA IgG Ab | Negative | HHV-8 DNA PCR | Negative |
| Total bilirubin | 0.7 mg/dL | PR3-ANCA | Negative | Bacterial cultures | |
| Asparate aminotransferase | 28 U/L | MPO-ANCA | Negative | Blood cultures | Negative |
| Alanine aminotransferase | 12 U/L | Anti-SS-A Ab | > 1200 U/mL | Ascitic fluid cultures | Negative |
| Lactate dehydrogenase | 278 U/L | Anti-SS-B Ab | Negative | Urine culture | Negative |
| Alkali phosphatase | 768 U/L | Anti-CL Ab | Negative | Urinalysis | |
| γ- glutamyltransferase | 129 U/L | Anti-CLβ2GPI Ab | Negative | Protein | (1+) |
| Amylase | 50 U/L | Anti-Scl-70 Ab | Negative | Occult blood | (−) |
| Creatine kinase | 694 U/L | Anti-RNP Ab | Negative | NAG | 44.8 U/L |
| Glucose | 121 mg/dL | Anti-Sm Ab | Negative | β2-MG | 81 μg/L |
| Hemoglobin A1c | 5.3% | Anti-mitochondrial M2 Ab | Negative | Granular casts | 10–19 /WF |
| Uric acid | 15.1 mg/dL | Anti-smooth muscle Ab | Negative | BJP | Negative |
β2-MG β2-microglobulin. Ab antibody, ANA antinuclear antibody, APTT activated partial thromboplastin time, BJP Bence Jones protein BNP brain natriuretic peptide, C3 complement component 3, C4 complement component 4, CA 19–9 carbohydrate antigen 19–9, CEA carcinoembryonic antigen, CH50 50% hemolytic complement activity, CL cardiolipin, CMV cytomegalovirus, ds-DNA double stranded-DNA, EBNA Epstein-Barr virus-nuclear antigen, EBV Epstein-Barr virus, GPI glycoprotein I, HBc Ab hepatitis B core antibody, HBs Ag hepatitis B surface antigen, HCV hepatitis C virus, HHV-8 human herpes virus-8, HIV human immunodeficiency virus, IFN-γ interferon-γ, Ig immunoglobulin, IL interleukin, IPF immature platelet fraction, MPO myeloperoxidase, NAG N-acetyl-β-D-glucosaminidase, PCR polymerase chain reaction, PR3-ANCA proteinase-3-anti-neutrophil cytoplasmic antibody, PT-INR prothrombin time-international normalized ratio, RF rheumatoid factor, RNP ribonucleoprotein, Scl scleroderma, Sm Smith, SS Sjögren syndrome, STS serologic test for syphilis, T3 triiodothyronine, T4 thyroxin, TSH Thyroid stimulating hormone, VEGF vascular endothelial cell growth factor, VCA viral capsid antigen, WF whole field